Clinical Trial Update: Optimizing HFrEF Patients Using BaroStim and CardioMems [Phase 2, Phase 3]

View source ↗

Summary

Clinical trials update describing Phase 2 and Phase 3 studies evaluating optimization of heart failure with reduced ejection fraction using BaroStim and CardioM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Barostim
• CardioMEMS

Snippet

Sponsor: Northwell Health | Conditions: Heart Failure NYHA Class III | Phase 2, Phase 3 | Status: RECRUITING